Kathryn Leung

3.5k total citations
50 papers, 2.1k citations indexed

About

Kathryn Leung is a scholar working on Oncology, Hematology and Epidemiology. According to data from OpenAlex, Kathryn Leung has authored 50 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 22 papers in Hematology and 21 papers in Epidemiology. Recurrent topics in Kathryn Leung's work include Cytomegalovirus and herpesvirus research (21 papers), Hematopoietic Stem Cell Transplantation (20 papers) and Virus-based gene therapy research (12 papers). Kathryn Leung is often cited by papers focused on Cytomegalovirus and herpesvirus research (21 papers), Hematopoietic Stem Cell Transplantation (20 papers) and Virus-based gene therapy research (12 papers). Kathryn Leung collaborates with scholars based in United States, France and Canada. Kathryn Leung's co-authors include Robert A. Krance, Helen E. Heslop, Malcolm K. Brenner, Cliona M. Rooney, Ann M. Leen, Adrian P. Gee, Catherine M. Bollard, George Carrum, Alana A. Kennedy‐Nasser and Caridad Martinez and has published in prestigious journals such as Nature Medicine, The Journal of Cell Biology and Blood.

In The Last Decade

Kathryn Leung

48 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathryn Leung United States	16	1.0k	839	727	627	511	50	2.1k
Alana A. Kennedy‐Nasser United States	13	1.3k 1.3×	396 0.5×	757 1.0×	669 1.1×	436 0.9×	23	2.1k
Guenther Koehne United States	25	898 0.9×	520 0.6×	695 1.0×	340 0.5×	777 1.5×	98	2.0k
Joanne Luider Canada	22	357 0.3×	157 0.2×	431 0.6×	455 0.7×	516 1.0×	55	1.4k
Lisa S. St. John United States	20	473 0.5×	345 0.4×	747 1.0×	117 0.2×	488 1.0×	50	1.4k
Rebecca Gardner United States	20	2.9k 2.8×	149 0.2×	714 1.0×	769 1.2×	344 0.7×	73	3.6k
Caterina Cancrini Italy	24	270 0.3×	298 0.4×	1.1k 1.6×	419 0.7×	129 0.3×	96	1.9k
Tessa Kerre Belgium	26	769 0.7×	121 0.1×	940 1.3×	214 0.3×	427 0.8×	112	2.1k
Antonio Pierini Italy	23	464 0.5×	312 0.4×	1.2k 1.7×	90 0.1×	694 1.4×	64	1.8k
David Peritt United States	19	325 0.3×	219 0.3×	1.5k 2.1×	201 0.3×	279 0.5×	34	2.1k
Hüseyin Firat France	27	488 0.5×	231 0.3×	1.2k 1.7×	264 0.4×	346 0.7×	55	2.3k

Countries citing papers authored by Kathryn Leung

Since Specialization

Citations

This map shows the geographic impact of Kathryn Leung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Leung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Leung more than expected).

Fields of papers citing papers by Kathryn Leung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Leung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Leung. The network helps show where Kathryn Leung may publish in the future.

Co-authorship network of co-authors of Kathryn Leung

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Leung. A scholar is included among the top collaborators of Kathryn Leung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Leung. Kathryn Leung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stenger, Elizabeth, Benjamin Watkins, Kuang‐Yueh Chiang, et al.. (2023). Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure. Blood Advances. 7(10). 2196–2205. 12 indexed citations

Naik, Swati, Ghadir Sasa, Bilal Omer, et al.. (2019). Myeloablative Conditioning with Alemtuzumab in Matched Related Donor Hematopoietic Cell Transplant for Sickle Cell Disease Prevents Graft-Versus-Host Disease without Compromising Engraftment. Biology of Blood and Marrow Transplantation. 25(3). S39–S39. 1 indexed citations

Naik, Swati, et al.. (2018). Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma. Pediatric Transplantation. 22(5). e13210–e13210. 8 indexed citations

Leung, Kathryn, Swati Naik, Stephen Gottschalk, et al.. (2017). Acute GvHD Incidence and Outcome: Single Center Experience. Biology of Blood and Marrow Transplantation. 23(3). S231–S231. 4 indexed citations

Tzannou, Ifigeneia, Kathryn Leung, Caridad Martinez, et al.. (2016). Safety and Preliminary Efficacy of "Ready to Administer" Cytomegalovirus (CMV)-Specific T Cells for the Treatment of Patients with Refractory CMV Infection. Blood. 128(22). 388–388. 1 indexed citations

Perna, Serena, Stephen Gottschalk, Vicky Torrano, et al.. (2015). Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic Stem Cell Transplant. Biology of Blood and Marrow Transplantation. 21(2). S148–S148. 2 indexed citations

Leung, Kathryn, et al.. (2015). Autoimmune Encephalitis Following Bone Marrow Transplantation. Pediatric Neurology. 53(3). 253–256. 21 indexed citations

Martinez, Caridad, Ghadir Sasa, Swati Naik, et al.. (2015). Allogeneic Stem Cell Transplantation in a Pediatric Patient with Whim Syndrome. Blood. 126(23). 5528–5528. 2 indexed citations

Kennedy‐Nasser, Alana A., Stephanie Ku, Yasmin Hazrat, et al.. (2014). Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity. Clinical Cancer Research. 20(8). 2215–2225. 145 indexed citations

10.

Παπαδοπούλου, Αναστασία, Usha L. Katari, Ulrike Gerdemann, et al.. (2014). Safety and clinical efficacy of rapidly-generated virus-specific T cells with activity against adv, EBV, CMV, HHV6 and BK virus administered after allogeneic hematopoietic stem cell transplant. Cytotherapy. 16(4). S7–S7. 1 indexed citations

11.

Zhou, Xiaoou, Antonio Di Stasi, Siok‐Keen Tey, et al.. (2014). Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene. Blood. 123(25). 3895–3905. 139 indexed citations

12.

Παπαδοπούλου, Αναστασία, Usha L. Katari, Ulrike Gerdemann, et al.. (2013). Safety and Clinical Efficacy Of Rapidly-Generated Virus-Specific T Cells With Activity Against Adv, EBV, CMV, HHV6 and BK Virus Administered After Allogeneic Hematopoietic Stem Cell Transplant. Blood. 122(21). 148–148. 3 indexed citations

13.

El‐Bietar, Javier, Caridad Martinez, Catherine M. Bollard, et al.. (2013). Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT). Biology of Blood and Marrow Transplantation. 19(2). S195–S196.

14.

Martinez, Caridad, Sweta Shah, William T. Shearer, et al.. (2011). Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease. Journal of Allergy and Clinical Immunology. 129(1). 176–183. 44 indexed citations

15.

Heslop, H E, Malcolm K. Brenner, George Carrum, et al.. (2010). Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution. Leukemia & lymphoma. 51(4). 664–670. 18 indexed citations

16.

Lin, Yu‐Feng, David R. Lairson, Wenyaw Chan, et al.. (2010). Children with acute leukemia: A comparison of outcomes from allogeneic blood stem cell and bone marrow transplantation. Pediatric Blood & Cancer. 56(1). 143–151. 5 indexed citations

17.

Leen, Ann M., Anne Christin, Gary D. Myers, et al.. (2009). Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood. 114(19). 4283–4292. 244 indexed citations

18.

Patel, Niraj, Javier Chinen, Howard M. Rosenblatt, et al.. (2009). Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning. Journal of Allergy and Clinical Immunology. 124(5). 1062–1069.e4. 33 indexed citations

19.

Kennedy‐Nasser, Alana A., Catherine M. Bollard, Gary D. Myers, et al.. (2008). Comparable Outcome of Alternative Donor and Matched Sibling Donor Hematopoietic Stem Cell Transplant for Children with Acute Lymphoblastic Leukemia in First or Second Remission Using Alemtuzumab in a Myeloablative Conditioning Regimen. Biology of Blood and Marrow Transplantation. 14(11). 1245–1252. 42 indexed citations

20.

Kennedy‐Nasser, Alana A., Kathryn Leung, Anita Mahajan, et al.. (2006). Comparable Outcomes of Matched-Related and Alternative Donor Stem Cell Transplantation for Pediatric Severe Aplastic Anemia. Biology of Blood and Marrow Transplantation. 12(12). 1277–1284. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact